These observations are predominantly attributed to biologic differences in these markers; specifically, RS is more sensitized to PR expression, whereas SUV is more strongly affected by histologic grade or Ki67 expression in ER-positive/HER2-negative cancers. Here, ERBB2 is linked to cancer.